14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 58 days ( 0 % )
Last Price $1.76 0 %
High/ Low $1.76 - $1.76 0%
Chg 7 Days N/A $1.76 $1.76
Chg 30 Days N/A $1.76 $1.76
Chg 12 mos 66.16 % $1.06 $1.76
Trend - 3 mos -0.660 % Width: 7.35 %
Trend - 12 mos 23.29 % Width: 77.15 %
Pred. range - 3 mos $1.74 - $1.87 -1.35 % - 5.90 %
Pred. range - 12 mos $1.75 - $3.10 -0.685 % - 75.93 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Dec 20, 2022 - 58 days
Short MA avg 12 mos Sell Dec 13, 2022 - 63 days
Long MA avg 12 mos Sell Mar 01, 2023 - 11 days
Short/Long MA avg 12 mos Sell Mar 01, 2023 - 11 days
Pivot Short Buy Dec 19, 2022 - 59 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Yumanity Therapeutics, Inc.

Yumanity Therapeutics. Yumanity Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of treatments for neurodegenerative diseases caused by protein misfolding. The company focuses on discovering disease-modifying therapies to treat neurodegenerative diseases, including Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, amyotrophic lateral sclerosis, and frontotemporal lobar degeneration. Its lead p... YMTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT